(PDF) Evaluation of LBM415 (NVP PDF-713), a Novel Peptide

Evaluation of LBM415 (NVP PDF-713), a Novel Peptide Deformylase Inhibitor, for Treatment of Experimental Mycoplasma Pneumoniae Pneumonia

Antimicrobial Agents and Chemotherapy - United States

doi 10.1128/aac.49.10.4128-4136.2005

Full Text

Abstract

Available in full text

Categories

Infectious Diseases

Date

October 1, 2005

Authors

Monica Fonseca-Aten

Christine M. Salvatore

Asunción Mejías

Susana Chávez-Bueno

George H. McCracken

Publisher

American Society for Microbiology

Related search

Role of the AcrAB-TolC Efflux Pump in Determining Susceptibility of Haemophilus Influenzae to the Novel Peptide Deformylase Inhibitor LBM415

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Azithromycin Treatment Failure in Macrolide-Resistant Mycoplasma Pneumoniae Pneumonia

European Respiratory Journal

Respiratory Medicine

English

Single-Dose Safety, Tolerability, and Pharmacokinetics of the Antibiotic GSK1322322, a Novel Peptide Deformylase Inhibitor

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Treatment of Mycoplasma Pneumonia: A Systematic Review

English

Changes in the Epidemiological Pattern of Mycoplasma Pneumoniae Pneumonia

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases

English

Proteomic Study of Peptide Deformylase Inhibition in Streptococcus Pneumoniae and Staphylococcus Aureus

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

[Retracted] Value of Serum Mycoplasma Pneumoniae Immunoglobulin in the Diagnosis of Mycoplasma-Related Pneumonia in Newborns

Experimental and Therapeutic Medicine

Cancer Research

English

Structure and Activity of Human Mitochondrial Peptide Deformylase, a Novel Cancer Target

English

Computational Approaches to Identify a Derivative of Galardin as an Inhibitor of Mycobacterial Peptide Deformylase

VAWKUM Transactions on Computer Sciences

English